retatrutide development status eli lilly fda approval Lilly's drug, not approved, accessed through experimental treatment program Phase 3 results for retatrutide

GLP-1 Weight Loss Injections GLP-1 weight loss injections are weekly shots received on the same day as your appointment

Gut hormones-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

Real Results: In the most recent head-to-head study comparing tirzepatide to semaglutide, people taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks

TAPI, a peptide-focused CDMO, has described deploying UV and RI monitoring alongside in-line mass spectrometry-based sequence verification to create a data-rich manufacturing environment that replaces retrospective batch testing with continuous in-process quality assurance

Hims & Hers is introducing the Service Appreciation Initiative, to give eligible U.S

Keep your fingers away from the dose counter so you can see it